PATH | VRL
Menu

Find resources

Total results with these characteristics: 158

Topic: Immunization financing

Page 6 of 8
Malaria Vaccine Decision-Making Framework

As the development of malaria vaccines accelerates, work is also underway on the policy front to pave the way for decisions on possible malaria vaccine use. Early planning is crucial to the successful adoption and introduction of a vaccine. To …

Author: PATH

Publication date: 2012

Navigating Vaccine Introduction: A Guide for Decision-Makers—Japanese Encephalitis

This six-part guide is designed to help country decision-makers understand the evidence around when to consider introducing Japanese Encephalitis (JE) vaccines, the potential benefits, how to incorporate JE vaccines into their country’s …

Author: PATH

Publication date: 2017

A New Approach to Planning for Immunization - WHO-UNICEF Guidelines for Developing a Comprehensive Multi-Year Plan (cMYP)

The Global Immunization Vision and Strategy (GIVS) for 2006 to 2015 provides a framework for policymakers and stakeholders to have a unified vision of immunization and a set of strategies from which countries can select those most suited to their …

Author: World Health Organization; United Nations Children's Fund

New Decade of Vaccines

In December 2010, global health leaders committed to making the next 10 years the Decade of Vaccines - to ensure discovery, development, and delivery of lifesaving vaccines globally, especially to the poorest countries. This special series of …

Author: Horton R, ed.

Publication date: 2011

Overcoming Challenges to Sustainable Immunization Financing: Early Experiences From GAVI Graduating Countries

This article, published in Health Policy and Planning, reports on a pilot approach to support the transition of five countries graduating out of financing assistance from Gavi, the Vaccine Alliance, in 2012. The pilot showed that the countries were …

Author: Saxenian H, Hecht R, Kaddar M, Schmitt S, Ryckman T, Cornejo S

Publication date: 2015

Pneumococcal AMC

This section on the GAVI Alliance's website provides information about the pilot pneumococcal Advance Market Commitment (AMC), which is an innovative funding mechanism. It incentivizes vaccine makers to produce suitable and affordable vaccines for …

Author: GAVI Alliance

Potential Cost-Effectiveness of Vaccination for Rotavirus Gastroenteritis in Eight Latin American and Caribbean Countries

Investigators developed a model using epidemiological evidence, country-specific cost estimates, and vaccine efficacy data to estimate the cost-effectiveness of rotavirus vaccination and determined that it would reduce health care expenses and …

Author: Rheingans R, Constenla D, Antil L, Innis B, Breuer T

Publication date: 2007

Prevention of Group B Streptococcal Disease in the First 3 Months of Life: Would Routine Maternal Immunization During Pregnancy Be Cost-Effective?

This article, published in Vaccine, reports the results of a study that evaluated the potential cost-effectiveness of a trivalent group B streptococcal (GBS) vaccine candidate with a decision-analytic model. The authors found that the addition of a …

Author: Oster G, Edelsberg J, Hennegan K, et al.

Publication date: 2014

The Problems and Promise of Vaccine Markets in Developing Countries

This article, published in Health Affairs, discusses a number of promising and innovative approaches that are being explored to increase the incentives and reduce the risks of investing in vaccines for developing countries. These approaches aim …

Author: Batson A

Publication date: 2005

Procurement and Pricing of New Vaccines for Developing Countries

Several vaccines that have come to market, including the rotavirus, pneumococcal conjugate, and human papillomavirus vaccines, have the potential to bring large public health benefits to developing countries. This eight-page policy brief explains …

Author: International AIDS Vaccine Initiative

Publication date: 2008

Progress in Cervical Cancer Prevention: The CCA Report Card

This report assesses global readiness to fight cervical cancer using new approaches and new technologies, especially in regions where the disease is a common killer. It underscores the urgent need for the global community to prioritize cervical …

Author: Cervical Cancer Action

Publication date: 2012

Projected Health and Economic Impact of Rotavirus Vaccination in GAVI-Eligible Countries: 2011–2030

This article, published in Vaccine, projects the cost-effectiveness and health impact of rotavirus vaccines in countries eligible for support from the GAVI Alliance. The authors used a decision-analytic model to project the health outcomes and …

Author: Atherly DE, Lewis KDC, Tate J, Parashar UD, Rheingans RD

Publication date: 2012

Projected Health Benefits and Costs of Pneumococcal and Rotavirus Vaccination in Uganda

The authors of this article, published in Vaccine, determined the impact and cost-effectiveness of pneumococcal and rotavirus vaccination programs among children younge than five years of age in Uganda from the public health system perspective. They …

Author: Tate JE, Kisakye A, Mugyenyi P, Kizza D, Odiit A, Braka F

Publication date: 2011

Projected Impact and Cost-Effectiveness of a Rotavirus Vaccination Program in India, 2008

The authors of this article, published in Clinical Infectious Diseases, aimed to determine the potential impact and cost-effectiveness of a national rotavirus vaccination program in India. They compared the national rotavirus disease and cost burden …

Author: Esposito DH, Tate JE, Kang G, Parashar UD

Publication date: 2011

Public Finance of Rotavirus Vaccination in India and Ethiopia: An Extended Cost-Effectiveness Analysis

This article, published in Vaccine, reports on a study that evaluated the potential impact of a publicly funded national rotavirus vaccination program in India and Ethiopia on reducing deaths and household costs due to rotavirus disease. The authors …

Author: Verguet S, Murphy S, Anderson B, Johansson KA, Glass R, Rheingans R

Publication date: 2013

Public Health Impact and Cost-Effectiveness of the RTS,S/AS01 Malaria Vaccine: A Systematic Comparison of Predictions From Four Mathematical Models

This article, published in The Lancet, reports the results of a study that aimed to assess the public health impact and cost-effectiveness of routine use of the RTS,S/AS01 vaccine in African settings. The models predict a significant public health …

Author: Penny MA, Verity R, Bever CA, et al.

Publication date: 2015

Pull Mechanisms for Value-Added Technologies for Vaccines

Project Optimize, a collaboration between PATH and the World Health Organization, commissioned this white paper to examine the issues influencing vaccine producer willingness to advance, adopt, and commercialize value-added technologies for …

Author: PATH, World Health Organization

Publication date: 2009

R&D for Diarrhoeal Diseases

While preventive measures such as clean drinking water and sanitation can reduce the risk of infection from diarrheal diseases, research and development (R&D) of new tools is equally important, particularly for vaccines as they can prevent …

Author: Policy Cures

Publication date: 2013

Reduced Price on Rotavirus Vaccines: Enough to Facilitate Access Where Most Needed?

This article, published in the Bulletin of the World Health Organization, examines whether the reduced prices for rotavirus vaccine are affordable enough to facilitate access to the vaccine where it is most needed. The study points to the rotavirus …

Author: Madsen LB, Ustrup M, Fischer TK, Bygbjerg IC, Konradsen F

Publication date: 2012

Refocusing Gavi for Greater Impact

This report outlines the large impact that Gavi, the Vaccine Alliance, has had on immunization rates in eligible countries through funding support and dispersal of vaccines. It also provides recommendations on how Gavi could have a greater impact. …

Author: Dykstra S, Glassman A, Kenny C, Sandefur J (Center for Global Development)

Publication date: 2015

Page 6 of 8